Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Pain Relief in Low Back Pain

ClinicalTrials.gov ID: NCT00325949

Public ClinicalTrials.gov record NCT00325949. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-Label Period Followed By a Randomized, Double-Blind, Placebo-Controlled Study of the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) Compared to Placebo in Subjects With Chronic Low Back Pain

Study identification

NCT ID
NCT00325949
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
770 participants

Conditions and interventions

Interventions

  • Extended release hydrocodone and acetaminophen (Vicodin CR) Drug
  • hydrocodone/acetaminophen extended release (Vicodin CR) Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
21 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2006
Primary completion
Apr 30, 2007
Completion
May 31, 2007
Last update posted
Jul 24, 2011

2006 – 2007

United States locations

U.S. sites
63
U.S. states
29
U.S. cities
55
Facility City State ZIP Site status
Site Ref # / Investigator 2216 Hueytown Alabama 35023
Site Ref # / Investigator 2605 Phoenix Arizona 85023
Site Ref # / Investigator 1990 Phoenix Arizona 85029
Site Ref # / Investigator 1974 Tempe Arizona 85282
Site Ref # / Investigator 1977 Tucson Arizona 85741
Site Ref # / Investigator 1992 Buena Park California 90620
Site Ref # / Investigator 1993 Burbank California 91505
Site Ref # / Investigator 2219 Fair Oaks California 95628
Site Ref # / Investigator 1989 Los Gatos California 95032
Site Ref # / Investigator 2157 Denver Colorado 80209
Site Ref # / Investigator 1994 Trumbull Connecticut 06611
Site Ref # / Investigator 2208 Clearwater Florida 33756
Site Ref # / Investigator 2210 DeLand Florida 32720
Site Ref # / Investigator 2207 Hollywood Florida 33023
Site Ref # / Investigator 2204 Miami Florida 33156
Site Ref # / Investigator 2205 Miami Florida 33186
Site Ref # / Investigator 2214 Oldsmar Florida 34677
Site Ref # / Investigator 2135 Plantation Florida 33324
Site Ref # / Investigator 2134 West Palm Beach Florida 33409-3509
Site Ref # / Investigator 1975 Atlanta Georgia 30328
Site Ref # / Investigator 1991 Decatur Georgia 30033
Site Ref # / Investigator 1985 Chicago Illinois 60610
Site Ref # / Investigator 1978 Evansville Indiana 47714
Site Ref # / Investigator 1988 West Des Moines Iowa 50265
Site Ref # / Investigator 2580 Prairie Village Kansas 66206
Site Ref # / Investigator 2209 Metairie Louisiana 70006
Site Ref # / Investigator 1976 Shreveport Louisiana 71103
Site Ref # / Investigator 2203 Pasadena Maryland 21122
Site Ref # / Investigator 2603 Brockton Massachusetts 02301
Site Ref # / Investigator 2156 Wellesley Hills Massachusetts 02481-2106
Site Ref # / Investigator 3420 Biloxi Mississippi 39531
Site Ref # / Investigator 2556 Florissant Missouri 63031
Site Ref # / Investigator 1980 St Louis Missouri 63141
Site Ref # / Investigator 1982 Missoula Montana 59802
Site Ref # / Investigator 1986 Omaha Nebraska 68134
Site Ref # / Investigator 3421 Las Vegas Nevada 89106
Site Ref # / Investigator 2206 Las Vegas Nevada 89123
Site Ref # / Investigator 1973 New York New York 10022
Site Ref # / Investigator 2578 Williamsville New York 14221
Site Ref # / Investigator 1983 Raleigh North Carolina 27609
Site Ref # / Investigator 2606 Raleigh North Carolina 27612
Site Ref # / Investigator 5161 Winston-Salem North Carolina 27103
Site Ref # / Investigator 2218 Cincinnati Ohio 45227
Site Ref # / Investigator 1995 Cincinnati Ohio 45242
Site Ref # / Investigator 1987 Cincinnati Ohio 45245
Site Ref # / Investigator 2211 Oklahoma City Oklahoma 73103
Site Ref # / Investigator 2215 Downingtown Pennsylvania 19335
Site Ref # / Investigator 2579 Duncansville Pennsylvania 16635
Site Ref # / Investigator 2213 Mechanicsburg Pennsylvania 17055
Site Ref # / Investigator 2137 Cranston Rhode Island 02920
Site Ref # / Investigator 2221 Greer South Carolina 29651
Site Ref # / Investigator 1984 Cordova Tennessee 38018
Site Ref # / Investigator 2217 Austin Texas 78705
Site Ref # / Investigator 2607 Bulverde Texas 78163
Site Ref # / Investigator 2590 Dallas Texas 75251
Site Ref # / Investigator 2117 Killeen Texas 76543
Site Ref # / Investigator 2604 Nederland Texas 77627
Site Ref # / Investigator 1979 Richardson Texas 75080
Site Ref # / Investigator 2212 San Angelo Texas 76904
Site Ref # / Investigator 1981 San Antonio Texas 78127
Site Ref # / Investigator 2220 San Antonio Texas 78209
Site Ref # / Investigator 2608 San Antonio Texas 78218
Site Ref # / Investigator 2158 Virginia Beach Virginia 23454

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00325949, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 24, 2011 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00325949 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →